Recently, Phantomics was honored with an Innovation Award in the Digital Healthcare category for its healthcare AI solution, Myomics.
 

Myomics is a non-invasive cardiac MRI image analysis technology that enables early diagnosis of heart disease and provides accuracy comparable to biopsy. It is even more meaningful to be the first Korean medical imaging AI company to receive this Award in recognition of the innovation of Myomics.

Phantomics will attend CES 2024 in LasVegas in January to showcase Myomics to healthcare professionals and the public.